Big Pharma markets left on a ‘patent cliff’-hanger

大型制药企业悬挂在“专利悬崖”的边缘

FT News Briefing

2025-07-11

11 分钟
PDF

单集简介 ...

India is set to reach a record year in initial public offerings and Big Pharma is facing a wave of patent expiration dates. Plus, Meta goes to trial over who to hold accountable for corporate scandals.  Mentioned in this podcast: India on track for record IPO year The looming ‘patent cliff’ facing Big Pharma  Today’s FT News Briefing was produced by Sonja Hutson, Katya Kumcova, Henry Larson and Marc Filippino. Additional help from Kelly Garry, and Michael Lello. Our acting co-head of audio is Topher Forhecz. Our intern is Michaela Seah. The show’s theme song is by Metaphor Music.  Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.
更多

单集文稿 ...

  • Is your team still wasting hours chasing down marketing data?

  • If you don't have the right tools, even great data slows you down.

  • Adverity's AI-powered data conversations make it easy to ask complex questions and get instant answers.

  • No code, no bottlenecks, just smarter decisions, faster.

  • From CMOs to analysts, the insights you need are just a question away.

  • Visit adverity.com and book a demo today.

  • Adverity.

  • What questions will you ask?

  • Good morning from the Financial Times.

  • Today is Friday, July 11th and this is your FT News Briefing.

  • India is having an IPO boom and Meta heads to court next week for an unusual trial.

  • Plus the pharmaceutical industry is speeding towards something called a patent cliff.

  • We'll tell you what that means for the sector.

  • I'm Mark Filipino and here's the news you need to start your day.

  • India now has the world's biggest initial public offering market outside the U.S.

  • The amount raised in primary public floatation so far this year hit $6.7 billion.

  • And a few highly anticipated listings are expected to push India past the $21 billion mark that was raised last year.

  • All this success comes on the back of India's interest rate cuts and a lot of demand for equities from domestic investors.

  • But there's a bit of a hang up.

  • New Delhi has not cut a trade deal with Washington yet.